According to KOBAYASHI Pharmaceutical's latest financial reports the company's current earnings are $1.08 Billion USD. a decrease over its 2023 earnings that were of $0.19 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | $92.26 M | -52.1% |
2023 | $0.19 B | -7.35% |
2022 | $0.20 B | -15.76% |
2021 | $0.24 B | -1.92% |
2020 | $0.25 B | 2.06% |
2019 | $0.24 B | 7.72% |
2018 | $0.22 B | 13.69% |
2017 | $0.20 B | |
2015 | $0.18 B | 0.54% |
2014 | $0.17 B | 4.28% |
2013 | $0.17 B | -33.79% |
2012 | $0.25 B | 58.02% |
2011 | $0.16 B | -20.1% |
2010 | $0.20 B | 14.4% |
2009 | $0.17 B |